null

The cartilage matrix synthesis pathway refers to the network of molecular and cellular mechanisms by which chondrocytes—the primary cell type in cartilage—produce, maintain, and remodel the extracellular matrix (ECM) of cartilage[1][2][3]. This process is regulated by anabolic growth factors (e.g., TGF-β, BMPs, IGF-1), transcriptional and epigenetic regulators (including certain microRNAs such as miR-1), and is balanced by catabolic factors (such as inflammatory cytokines and matrix-degrading enzymes like MMP-13)[1][4][5]. The ECM is mainly composed of type II collagen and the proteoglycan aggrecan, with contributions from other collagens (types IX, XI, X) and non-collagenous proteins[1][2][3][4]. Dysregulation of this pathway can result in insufficient cartilage repair, degeneration (as in osteoarthritis), or abnormal growth and calcification.

Other names

Cartilage matrix synthesisChondrogenesis signaling pathwayCartilage ECM synthesis pathway

Modulation of signaling pathways (e.g., activation/inhibition of TGF-β, BMP, Wnt, IGF, FGF, and hedgehog pathways); Regulation of gene transcription relevant to ECM production (collagen, aggrecan); Epigenetic regulation (e.g., miRNA-mediated)